This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall objective of this project is to compare the efficacy and safety of intermittent Neosten (slow release sodium fluoride) and continuous Citracal (calcium citrate) therapy with those of Fosamax (alendronate) and calcium citrate in the treatment of postmenopausal osteoporosis.
Showing the most recent 10 out of 693 publications